OpGen, Inc. (NASDAQ:OPGN) Q2 2023 Earnings Call Transcript
Operator: Welcome to OpGen’s Second Quarter 2023 Earnings Call and Business Update.
Opgen Inc (OPGN)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $999,998.00 | 514,138 | Large Shareholder | 7,645,603 | 2024-08-29 | Filing | |
| $999,999.00 | 564,971 | Large Shareholder | 7,131,465 | 2024-08-27 | Filing | |
| $2,724,490.00 | 3,600,000 | Large Shareholder | 6,566,494 | 2024-08-16 | Filing | |
| $428,724.00 | 566,494 | Large Shareholder | 2,966,494 | 2024-08-13 | Filing | |
| $0.85 | 25,000 | Officer | 60,000 | 2022-01-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $454,082.00 | 600,000 | Large Shareholder | 2,400,000 | 2024-08-08 | Filing | |
| $913,265.00 | 1,800,000 | Large Shareholder | 1,800,000 | 2024-08-05 | Filing | |
| $2.35 | 1,748 | Director | 21,734 | 2020-10-27 | Filing | |
| $2.19 | 3,612 | Director | 23,482 | 2020-09-04 | Filing | |
| $2.20 | 19 | 0 | 2020-05-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,327.5 | $22,376 | 0% | |
| 2. | 3,675.5 | $15,440 | 0% | |
| 3. | 1,604 | $6,737 | 0% | |
| 4. | 1,210.2 | $5,083 | 0% | |
| 5. | 724.2 | $3,042 | 0% |
News See All
OpGen, Inc. (NASDAQ:OPGN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the OpGen First Quarter 2023 Earnings Call and Business Update.
OpGen, Inc. (NASDAQ:OPGN) Q4 2022 Earnings Call Transcript
Operator: Welcome to the OpGen Fourth Quarter and Full Year 2022 Earnings Call and Business Update.
OpGen, Inc. (NASDAQ:OPGN) Q3 2022 Earnings Call Transcript
Operator: Welcome to the OpGen Third Quarter 2022 Earnings Call and Business Update. Today, OpGen management will provide an update on the company's current business and outlook for the future.
Is OpGen, Inc. (OPGN) A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards OpGen, Inc. (NASDAQ:OPGN) and determine whether it is a good investment right now.
Hedge Fund and Insider Trading News: James Dinan, ExodusPoint Capital, Marriott Vacations Worldwide Corp (VAC), OpGen Inc (OPGN), and More
Stephen Marley comes from music royalty. Sean Garrett has written and produced smash hits for Beyoncé, Usher and Ciara.
Here's What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why It's So Important
OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical giant Merck & Co., Inc. (NYSE:MRK).
Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape
Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually on a hunch.